The Group's principal activities are developing, manufacturing and selling the Hi Art system, return to Navigational Table of Contents an advanced and versatile radiation therapy system for the treatment of a wide variety of cancers. It markets the System to hospitals and cancer treatment centers. The Hi Art system precisely delivers radiation with sub-millimeter accuracy to kill cancer cells while reducing radiation exposure to surrounding healthy tissue, which we believe, can lead to improved patient outcomes. TomoTherapy(R), Tomo(R), Hi Art(R) and the TomoTherapy logo are registered trademarks of the Group. It operates in Europe, U.S. and Asia.
Alacra Alerts:
Receive alerts on the latest reports on Tomotherapy Incorporated
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
